IOVANCE BIOTHERAPEUTICS, INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2016 | -31.7% | -31.7% | -30.8% |
| FY2017 | -63.3% | -63.3% | -59.3% |
| FY2018 | -26.5% | -26.5% | -25.7% |
| FY2019 | -66.1% | -66.1% | -57.3% |
| FY2020 | -39.5% | -39.5% | -33.8% |
| FY2021 | -55.1% | -55.1% | -44.0% |
| FY2022 | -79.2% | -79.2% | -59.6% |
| FY2023 | -76.0% | -76.0% | -56.9% |
| FY2024 | -52.4% | -52.4% | -40.9% |
| FY2025 | -56.0% | -56.0% | -42.8% |